Reuters
Search documents
Nordic Capital, Permira takeover offer for Bavarian Nordic falls through
Reuters· 2025-11-06 14:29
Innosera, a consortium led by Nordic Capital and Permira, failed to achieve the required level of support from shareholders for its planned takeover of Bavarian Nordic and will withdraw its bid, Bavar... ...
Papa John's focused on executing its strategy but open to alternatives, CEO says
Reuters· 2025-11-06 14:16
Papa John's CEO Todd Penegor on Thursday said the U.S. pizza chain is focusing on executing its strategy to drive value, but noted it would consider alternatives if they were available. ...
Microsoft launches 'superintelligence' team targeting medical diagnosis to start
Reuters· 2025-11-06 14:04
Core Insights - Microsoft is establishing a new team focused on developing artificial intelligence that surpasses human capabilities in specific areas, with an initial emphasis on medical diagnostics [1] Group 1 - The new team aims to create AI that is significantly more capable than humans in certain domains [1] - The first application of this advanced AI will be in the field of medical diagnostics [1]
Becton sees 2026 profit slightly above estimates on strong demand for drug delivery devices
Reuters· 2025-11-06 13:58
Medical device maker Becton Dickinson on Thursday topped Wall Street estimates for fourth-quarter adjusted profit and forecast 2026 earnings slightly above expectations, supported by steady demand for... ...
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle
Reuters· 2025-11-06 13:49
Core Insights - A bidding war is intensifying over U.S. biotech Metsera, with Danish drugmaker Novo Nordisk and U.S. rival Pfizer competing for Metsera's obesity drug assets valued at $10 billion [1] Company Summary - Novo Nordisk is engaged in a competitive bidding process to acquire Metsera's obesity drug assets [1] - Pfizer is also vying for the same assets, indicating a significant interest in the obesity treatment market [1] Industry Summary - The competition for Metsera highlights the growing importance of obesity drug development within the biotech and pharmaceutical industries [1] - The $10 billion valuation of Metsera's assets reflects the high stakes and potential profitability associated with obesity treatments [1]
NRG Energy forecasts higher 2026 core profit on strong power demand
Reuters· 2025-11-06 13:45
NRG Energy on Thursday forecast standalone core profit for full-year 2026 over its updated range for 2025 on the back of surging power demand, sending the utility firm's shares up 1% in premarket trad... ...
Vistra forecasts higher 2026 core earnings on rising US power demand
Reuters· 2025-11-06 13:39
Vistra Corp on Thursday forecast 2026 adjusted core profit higher than its outlook for the current year, signaling confidence in its growing power generation portfolio and strong demand across U.S. ma... ...
Utility Evergy misses quarterly profit estimates, narrows 2025 forecast due to cooler summers
Reuters· 2025-11-06 13:35
Utility Evergy on Thursday missed the Wall Street adjusted profit estimates for the third quarter and trimmed the upper end of its 2025 adjusted earnings forecast due to the impact of milder summer we... ...
Adani unit signs deal with Australia's Caravel Minerals copper project
Reuters· 2025-11-06 13:30
India's Adani Enterprises said on Thursday its unit Kutch Copper Ltd (KCL) has signed a non-binding deal with Australia's Caravel Minerals to accelerate development of a copper project in Western Aust... ...
Rockwell tops fourth-quarter profit, revenue estimates on automation demand
Reuters· 2025-11-06 13:29
Rockwell Automation topped fourth-quarter estimates for profit and revenue on Thursday, helped by cost cuts and sustained demand for automation, sending its shares up about 5% in premarket trading. ...